EcoDrugPlus

Ribosomal Protein Sa

Ensembl ID : ENSG00000168028
Gene: RPSA
Gene Synonyms: 37LRP,LAMR1,LRP,P40,SA
4 APIs:
47 Enzyme and pathways 9 Cross references
191 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSG00000089157
Gene: RPLP0
Gene Synonyms: L10E,LP0,P0,PRLP0,RPP0
4 APIs:
42 Enzyme and pathways 7 Cross references
178 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSG00000137818
Gene: RPLP1
Gene Synonyms: LP1
4 APIs:
36 Enzyme and pathways 7 Cross references
256 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Secretin Receptor

Ensembl ID : ENSG00000080293
Gene: SCTR
Gene Synonyms:
3 APIs:
7 Enzyme and pathways 7 Cross references
130 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Selectin E

Ensembl ID : ENSG00000007908
Gene: SELE
Gene Synonyms: CD62E,ELAM,ELAM1,ESEL
3 APIs:
2 Enzyme and pathways 7 Cross references
236 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Selectin L

Ensembl ID : ENSG00000188404
Gene: SELL
Gene Synonyms: CD62L,HLHRC,LAM-1,LAM1,LEU-8,LNHR,LSEL,LYAM-1,LYAM1,PLNHR
2 APIs:
7 Enzyme and pathways 7 Cross references
86 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Selectin P

Ensembl ID : ENSG00000174175
Gene: SELP
Gene Synonyms: CD62,CD62P,GMP140,GRMP,PADGEM,PSEL
4 APIs:
5 Enzyme and pathways 7 Cross references
120 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Serpin Family C Member 1

Ensembl ID : ENSG00000117601
Gene: SERPINC1
Gene Synonyms: AT3,ATIII,MGC22579
10 APIs:
8 Enzyme and pathways 9 Cross references
200 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSG00000147955
Gene: SIGMAR1
Gene Synonyms: OPRS1,SR-BP1
6 APIs:
4 Enzyme and pathways 8 Cross references
206 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Sirtuin 1

Ensembl ID : ENSG00000096717
Gene: SIRT1
Gene Synonyms: SIR2L1
1 APIs:
14 Enzyme and pathways 7 Cross references
159 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSG00000128602
Gene: SMO
Gene Synonyms: FZD11,SMOH
9 APIs:
12 Enzyme and pathways 9 Cross references
203 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Sodium Channel Epithelial 1 Subunit Alpha

Ensembl ID : ENSG00000111319
Gene: SCNN1A
Gene Synonyms: ENACALPHA,SCNN1
3 APIs:
6 Enzyme and pathways 8 Cross references
153 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).